Abstract

Advancements in genomics have significantly enhanced our understanding of cancer etiology, progression, and treatment. This article explores how genomic insights are reshaping cancer epidemiology, particularly in diverse populations. We examine the implications of genomic diversity on cancer susceptibility, the role of precision medicine, and the challenges in ensuring equitable access to genomic technologies. Through this lens, we aim to highlight the potential and limitations of integrating genomic data into cancer epidemiology and public health strategies.